Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 211, Issue 5, Pages 680-688Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiu467
Keywords
falciparum malaria; artemisinin resistance; drug resistance; molecular epidemiology
Categories
Funding
- National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [K08AI10092, R01AI089819, R56AI097909, U19AI089674]
- NIH [KL2RR031981, T32GM0088719]
- Malaria in Pregnancy Consortium - Bill and Melinda Gates Foundation [46099]
- Medical Research Council [MC_UP_A900_1118] Funding Source: researchfish
- MRC [MC_UP_A900_1118] Funding Source: UKRI
Ask authors/readers for more resources
Plasmodium falciparum parasites that are resistant to artemisinins have been detected in Southeast Asia. Resistance is associated with several polymorphisms in the parasite's K13-propeller gene. The molecular epidemiology of these artemisinin resistance genotypes in African parasite populations is unknown. We developed an assay to quantify rare polymorphisms in parasite populations that uses a pooled deep-sequencing approach to score allele frequencies, validated it by evaluating mixtures of laboratory parasite strains, and then used it to screen P. falciparum parasites from >1100 African infections collected since 2002 from 14 sites across sub-Saharan Africa. We found no mutations in African parasite populations that are associated with artemisinin resistance in Southeast Asian parasites. However, we observed 15 coding mutations, including 12 novel mutations, and limited allele sharing between parasite populations, consistent with a large reservoir of naturally occurring K13-propeller variation. Although polymorphisms associated with artemisinin resistance in P. falciparum in Southeast Asia are not prevalent in sub-Saharan Africa, numerous K13-propeller coding polymorphisms circulate in Africa. Although their distributions do not support a widespread selective sweep for an artemisinin-resistant phenotype, the impact of these mutations on artemisinin susceptibility is unknown and will require further characterization. Rapid, scalable molecular surveillance offers a useful adjunct in tracking and containing artemisinin resistance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available